A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.

Saved in:
Bibliographic Details
Title: A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.
Authors: Werner TL; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Ray A; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Lamb JG; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., VanBrocklin M; Department of Surgery, University of Utah, Salt Lake City, UT., Hueftle K; Department of Medicine, University of Utah, Salt Lake City, UT., Cohen AL; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Beck AC; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Buys SS; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Dyess DL; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL., Butler TW; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL., Dumlao TL; Banner M.D. Anderson Cancer Center, Gilbert, AZ., Neumayer L; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT; Department of Surgery, University of Arizona, Tucson, AZ., Khong HT; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL; Department of Breast Oncology, Moffitt Cancer Center, Tampa, FL. Electronic address: hung.khong@moffitt.org.
Source: Clinical breast cancer [Clin Breast Cancer] 2017 Nov; Vol. 17 (7), pp. 503-509. Date of Electronic Publication: 2017 Apr 29.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28579139
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Werner+TL%22">Werner TL</searchLink>; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Ray+A%22">Ray A</searchLink>; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Lamb+JG%22">Lamb JG</searchLink>; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22VanBrocklin+M%22">VanBrocklin M</searchLink>; Department of Surgery, University of Utah, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Hueftle+K%22">Hueftle K</searchLink>; Department of Medicine, University of Utah, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Cohen+AL%22">Cohen AL</searchLink>; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Beck+AC%22">Beck AC</searchLink>; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Buys+SS%22">Buys SS</searchLink>; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Dyess+DL%22">Dyess DL</searchLink>; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL.<br /><searchLink fieldCode="AU" term="%22Butler+TW%22">Butler TW</searchLink>; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL.<br /><searchLink fieldCode="AU" term="%22Dumlao+TL%22">Dumlao TL</searchLink>; Banner M.D. Anderson Cancer Center, Gilbert, AZ.<br /><searchLink fieldCode="AU" term="%22Neumayer+L%22">Neumayer L</searchLink>; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT; Department of Surgery, University of Arizona, Tucson, AZ.<br /><searchLink fieldCode="AU" term="%22Khong+HT%22">Khong HT</searchLink>; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL; Department of Breast Oncology, Moffitt Cancer Center, Tampa, FL. Electronic address: hung.khong@moffitt.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100898731%22">Clinical breast cancer</searchLink> [Clin Breast Cancer] 2017 Nov; Vol. 17 (7), pp. 503-509. <i>Date of Electronic Publication: </i>2017 Apr 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100898731 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0666 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215268209%22">15268209 </searchLink><i>NLM ISO Abbreviation: </i>Clin Breast Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28579139
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clbc.2017.04.010
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 503
    Titles:
      – TitleFull: A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Werner TL
      – PersonEntity:
          Name:
            NameFull: Ray A
      – PersonEntity:
          Name:
            NameFull: Lamb JG
      – PersonEntity:
          Name:
            NameFull: VanBrocklin M
      – PersonEntity:
          Name:
            NameFull: Hueftle K
      – PersonEntity:
          Name:
            NameFull: Cohen AL
      – PersonEntity:
          Name:
            NameFull: Beck AC
      – PersonEntity:
          Name:
            NameFull: Buys SS
      – PersonEntity:
          Name:
            NameFull: Dyess DL
      – PersonEntity:
          Name:
            NameFull: Butler TW
      – PersonEntity:
          Name:
            NameFull: Dumlao TL
      – PersonEntity:
          Name:
            NameFull: Neumayer L
      – PersonEntity:
          Name:
            NameFull: Khong HT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2017 Nov
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0666
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Clinical breast cancer
              Type: main
ResultId 1